$0.55
5.66% today
Nasdaq, Apr 03, 06:16 pm CET
ISIN
US00444T1007
Symbol
TLPH
Sector
Industry

AcelRx Pharmaceuticals, Inc. Target price 2025 - Analyst rating & recommendation

AcelRx Pharmaceuticals, Inc. Classifications & Recommendation:

Buy
100%

AcelRx Pharmaceuticals, Inc. Price Target

Target Price $4.33
Price $0.58
Potential
Number of Estimates 3
3 Analysts have issued a price target AcelRx Pharmaceuticals, Inc. 2026 . The average AcelRx Pharmaceuticals, Inc. target price is $4.33. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 3 analysts: 3 Analysts recommend AcelRx Pharmaceuticals, Inc. to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the AcelRx Pharmaceuticals, Inc. stock has an average upside potential 2026 of . Most analysts recommend the AcelRx Pharmaceuticals, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -0.50 -0.53
61.24% 6.00%
P/E negative

2 Analysts have issued a AcelRx Pharmaceuticals, Inc. forecast for earnings per share. The average AcelRx Pharmaceuticals, Inc. EPS is

$-0.53
Unlock
. This is
3.92% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.48 5.88%
Unlock
, the lowest is
$-0.57 11.76%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.50 61.24%
2025
$-0.53 6.00%
Unlock
2026
$-0.64 20.75%
Unlock
2027
$-0.29 54.69%
Unlock
2028
$0.22 175.86%
Unlock
2029
$0.91 313.64%
Unlock

P/E ratio

Current -1.15 64.29%
2025
-1.11 3.48%
Unlock
2026
-0.92 17.12%
Unlock
2027
-2.05 122.83%
Unlock
2028
2.65 229.27%
Unlock
2029
0.64 75.85%
Unlock

Current AcelRx Pharmaceuticals, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
HC Wainwright & Co.
Locked
Locked
Locked Apr 01 2025
HC Wainwright & Co.
Locked
Locked
Locked Jan 21 2025
Analyst Rating Date
Locked
HC Wainwright & Co.:
Locked
Locked
Apr 01 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Jan 21 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today